SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-041168
Filing Date
2023-02-16
Accepted
2023-02-16 17:04:35
Documents
18
Period of Report
2023-02-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d424770d8k.htm   iXBRL 8-K 30463
2 EX-4.1 d424770dex41.htm EX-4.1 94478
3 EX-5.1 d424770dex51.htm EX-5.1 19628
4 EX-10.1 d424770dex101.htm EX-10.1 154214
5 EX-10.2 d424770dex102.htm EX-10.2 154195
9 GRAPHIC g424770g0216023707988.jpg GRAPHIC 1812
10 GRAPHIC g424770page19a.jpg GRAPHIC 10693
  Complete submission text file 0001193125-23-041168.txt   716468

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA grtx-20230215.xsd EX-101.SCH 2853
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE grtx-20230215_lab.xml EX-101.LAB 17978
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grtx-20230215_pre.xml EX-101.PRE 11260
12 EXTRACTED XBRL INSTANCE DOCUMENT d424770d8k_htm.xml XML 3347
Mailing Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355
Business Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Filer) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39114 | Film No.: 23639268
SIC: 2834 Pharmaceutical Preparations